Brief: DURECT Reaches Enrollment Milestone In Phase 2B Ahfirm Trial
06/10/2022 14:02
Oct 6 (Reuters) - DURECT Corp DRRX.O :
* DURECT REACHES ENROLLMENT MILESTONE IN PHASE 2B AHFIRM
TRIAL
Source text for Eikon: ID:nPn1sltpWa
Further company coverage: DRRX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on DURECT
See all newsBrief: Bausch Health Completes Acquisition Of Durect Corporation, Expanding Late-Stage Liver Disease Portfolio
Durect Corp Reports Results For The Quarter Ended June 30: Earnings Summary
Brief: Durect Bausch Health Extend Tender Offer Date To Aug 12 - SEC Filing
Durect Corp Expected To Post A Loss Of 12 Cents A Share: Earnings Preview
Durect Corp Reports Results For The Quarter Ended March 31: Earnings Summary